George Davis
Vermögen: 5 Mio $ am 31.05.2026
Vermögen: 5 Mio $ am 31.05.2026
Derzeit hat George Eric Davis die Position des Secretary, Executive VP & General Counsel von BioMarin Pharmaceutical, Inc. und Secretary & Director bei Biomarin (U.K.) Ltd. (eine Tochtergesellschaft von BioMarin Pharmaceutical, Inc.). In der Vergangenheit war er Principal bei Paul, Hastings, Janofsky & Walker LLP. Herr Davis erwarb einen Bachelor-Abschluss an der University of California, Berkeley und einen Master-Abschluss an der University of San Francisco School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2026 | 78’560 ( 0.04% ) | 5 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | General Counsel | 01.03.2004 |
| INOZYME PHARMA, INC. | Präsident | 01.07.2025 |
| AMICUS THERAPEUTICS, INC. | Präsident | 27.04.2026 |
Biomarin (U.K.) Ltd.
Biomarin (U.K.) Ltd. Medical DistributorsDistribution Services Distributes pharmaceutical products | Direktor/Vorstandsmitglied | 23.12.2009 |
| Unternehmen | Position | Ende |
|---|---|---|
Paul, Hastings, Janofsky & Walker LLP
Paul, Hastings, Janofsky & Walker LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.01.2004 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Paul, Hastings, Janofsky & Walker LLP
Paul, Hastings, Janofsky & Walker LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biomarin (U.K.) Ltd.
Biomarin (U.K.) Ltd. Medical DistributorsDistribution Services Distributes pharmaceutical products | Distribution Services |
The University of San Francisco School of Law
The University of San Francisco School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inozyme Pharma, Inc.
Inozyme Pharma, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen